File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: The effect of tumor derived HMBG1 on intra-tumoral B cells in esophageal squamous cell carcinoma

TitleThe effect of tumor derived HMBG1 on intra-tumoral B cells in esophageal squamous cell carcinoma
Authors
Issue Date2018
PublisherOxford University Press. The Journal's web site is located at http://annonc.oxfordjournals.org/
Citation
European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2018, Geneva, Switzerland, 13-16 December 2018. In Annals of Oncology, 2018, v. 29 n. Suppl.10, p. x7-x8 How to Cite?
AbstractBackground: Tumor microenvironment (TME) is often hypoxic and characterized by diverse cell populations (tumor cells and lymphocytes). An intranuclear architectural protein termed high mobility group box chromosomal protein 1 (HMGB-1) is enriched in hypoxic environment, where it acts as a chemokine to promote recruitment of inflammatory cells. We studied the effect of tumor derived HMBG1 on B cell migration and phenotype differentiation in esophageal squamous cell carcinoma (ESCC). Methods: Immunohistochemistry (IHC) staining for HMGB-1 was performed on tissue microarray (TMA) of ESCC and correlated with survival outcome. An immunostaining scoring system corresponding to total staining intensity as follows; (strong staining score =3; moderate staining score=2; weak staining scores= 1; no staining scores= 0). Co-staining with CD20+B was also performed to study B cells distribution in the tumor. ESCC cell lines were transfected with HMGB-1 and transwell migration of B cells were studied. Results: TMA containing 78 paired primary tumors and normal tissue from ESCC patients was analyzed by IHC using an anti-HMGB1 antibody. We found that HMGB1 was expressed at a higher level as compared to paired normal tissue. Survival curves were estimated by the Kaplan-Meier method and compared with log-rank test to evaluate the relationship between biomarker HMGB1 and survival outcomes. Patients were divided into two groups based on the optimal cutoffs of low (score 0-1), high (score 2-3) staining of HMGB1, we found out that HMGB1 staining were not correlated to patient survivals (p = 0.363). We then performed double-staining and demonstrated that B cells were located in the stroma along HMGB1-stained tumor. Stable HMGB1 ESCC cell lines were established where boyden chamber and wound-healing assays demonstrated that B cells migrated and proliferated at higher rates towards HMGB1-overexpressing cell lines. Conclusions: Our findings indicate that HMGB1 was over-expressed in tumor compared with normal tissue. HMGB1 expression per se was not correlated to survival in our log-rank analysis. HMGB1 expression has probable role in B cells recruitment, migration/proliferation.
DescriptionPoster Session - No. 23P
Persistent Identifierhttp://hdl.handle.net/10722/275381
ISSN
2021 Impact Factor: 51.769
2020 SCImago Journal Rankings: 7.954

 

DC FieldValueLanguage
dc.contributor.authorKwong, DLW-
dc.contributor.authorKam, YN-
dc.contributor.authorGuan, XY-
dc.date.accessioned2019-09-10T02:41:25Z-
dc.date.available2019-09-10T02:41:25Z-
dc.date.issued2018-
dc.identifier.citationEuropean Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2018, Geneva, Switzerland, 13-16 December 2018. In Annals of Oncology, 2018, v. 29 n. Suppl.10, p. x7-x8-
dc.identifier.issn0923-7534-
dc.identifier.urihttp://hdl.handle.net/10722/275381-
dc.descriptionPoster Session - No. 23P-
dc.description.abstractBackground: Tumor microenvironment (TME) is often hypoxic and characterized by diverse cell populations (tumor cells and lymphocytes). An intranuclear architectural protein termed high mobility group box chromosomal protein 1 (HMGB-1) is enriched in hypoxic environment, where it acts as a chemokine to promote recruitment of inflammatory cells. We studied the effect of tumor derived HMBG1 on B cell migration and phenotype differentiation in esophageal squamous cell carcinoma (ESCC). Methods: Immunohistochemistry (IHC) staining for HMGB-1 was performed on tissue microarray (TMA) of ESCC and correlated with survival outcome. An immunostaining scoring system corresponding to total staining intensity as follows; (strong staining score =3; moderate staining score=2; weak staining scores= 1; no staining scores= 0). Co-staining with CD20+B was also performed to study B cells distribution in the tumor. ESCC cell lines were transfected with HMGB-1 and transwell migration of B cells were studied. Results: TMA containing 78 paired primary tumors and normal tissue from ESCC patients was analyzed by IHC using an anti-HMGB1 antibody. We found that HMGB1 was expressed at a higher level as compared to paired normal tissue. Survival curves were estimated by the Kaplan-Meier method and compared with log-rank test to evaluate the relationship between biomarker HMGB1 and survival outcomes. Patients were divided into two groups based on the optimal cutoffs of low (score 0-1), high (score 2-3) staining of HMGB1, we found out that HMGB1 staining were not correlated to patient survivals (p = 0.363). We then performed double-staining and demonstrated that B cells were located in the stroma along HMGB1-stained tumor. Stable HMGB1 ESCC cell lines were established where boyden chamber and wound-healing assays demonstrated that B cells migrated and proliferated at higher rates towards HMGB1-overexpressing cell lines. Conclusions: Our findings indicate that HMGB1 was over-expressed in tumor compared with normal tissue. HMGB1 expression per se was not correlated to survival in our log-rank analysis. HMGB1 expression has probable role in B cells recruitment, migration/proliferation.-
dc.languageeng-
dc.publisherOxford University Press. The Journal's web site is located at http://annonc.oxfordjournals.org/-
dc.relation.ispartofAnnals of Oncology-
dc.relation.ispartofESMO Immuno-Oncology Congress 2018-
dc.rightsPre-print: Journal Title] ©: [year] [owner as specified on the article] Published by Oxford University Press [on behalf of xxxxxx]. All rights reserved. Pre-print (Once an article is published, preprint notice should be amended to): This is an electronic version of an article published in [include the complete citation information for the final version of the Article as published in the print edition of the Journal.] Post-print: This is a pre-copy-editing, author-produced PDF of an article accepted for publication in [insert journal title] following peer review. The definitive publisher-authenticated version [insert complete citation information here] is available online at: xxxxxxx [insert URL that the author will receive upon publication here].-
dc.titleThe effect of tumor derived HMBG1 on intra-tumoral B cells in esophageal squamous cell carcinoma-
dc.typeConference_Paper-
dc.identifier.emailKwong, DLW: dlwkwong@hku.hk-
dc.identifier.emailGuan, XY: xyguan@.hku.hk-
dc.identifier.authorityKwong, DLW=rp00414-
dc.identifier.authorityGuan, XY=rp00454-
dc.identifier.doi10.1093/annonc/mdy493.021-
dc.identifier.hkuros303431-
dc.identifier.hkuros308054-
dc.identifier.volume29-
dc.identifier.issueSuppl.10-
dc.identifier.spagex7-
dc.identifier.epagex8-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl0923-7534-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats